Elevate Medical Affairs Podcast Channel

MAPS speaks with Tim Mikhelashvili about metrics to communicate the strategic value of Medical Affairs activities, and specifically about the Medical Productivity Index (MPI), which seeks to quantify aspects of Medical Affairs including the MSL/HCP relationship and an individual's impact on patient outcomes. To learn more about the MPI and to add your voice to further development of this important metric, join Tim and co-presenters March 21 at the MAPS 2022 Global Annual Meeting in New Orleans!

In this episode of the Elevate podcast series, MAPS speaks with Bozidar Jovicevic, former VP at Sanofi and Novartis and now a CEO of Evermed, about the opportunity the pandemic presented for pharma to rethink the ways they engage with HCPs. Gone is the model of HCPs being always available to MSL presenting a slide deck. Today, Medical Affairs teams are taking a technology-powered, HCP-centric approach to scientific exchange, using personalized, on-demand, video content and data to understand HCP preferences that can inform subsequent MSL interactions. Learn how your Medical Affairs team can implement a Netflix-like, education streaming strategy to obtain direct access to HCPs, engage them repeatedly, and accelerate product launches and adoption.

Medical Affairs is specifically tasked with optimizing the real-world use of new drugs and yet clinical trial participation remains an imperfect (at best) representation of real-world patient populations. This podcast details ways to identify and engage diverse patients in Medical Affairs clinical trials, empowering the function’s core mission to maximize the benefit of new pharmaceutical and MedTech products to patients in the wider healthcare landscape.

This podcast series will focus on how digital is transforming scientific communications. Episode 3 will focus on publication metrics, specifically on how article-level metrics are impacting and creating new opportunities for medical publication and what metrics we should be tracking.

As Medical Affairs professionals, we are starting to capitalize on the promise of Real-World Evidence. However, the more we accomplish, the more untapped potential we see. This podcast looks beyond the obvious uses of RWE to explore emerging opportunities for Medical Affairs professionals and teams to leverage this powerful source of data to benefit patients.

This podcast series will focus on how digital is transforming scientific communications. Episode 2 will focus on different forms of enhanced publication content (EPC) and new approaches that might change manuscript development.

Medical Affairs was conceptualized in a primarily executional role, closely linked with an organization’s sales function. Now, as Medical Affairs has become the organization’s voice of scientific expertise, and in a climate of increased patient-centricity and increased scrutiny, Medical Affairs has taken on an increasingly strategic role. Here MAPS speaks with Ariel Katz, co-founder and CEO of H1 Insights about the factors driving the evolution of Medical Affairs and look at the shape of the function in 2030 and beyond.

This podcast series will focus on how digital is transforming scientific communications.  Episode 1 will focus on the journal publishing industry, discussing how medical journal publishing is changing and what changes we might see in the future.

In this podcast, Kirk Shepard, Chief Medical Officer & SVP, Head of Global Medical Affairs OBG at Eisai, speaks with Ghazaleh EA, pharmacist and new industry professional. The conversation explores Ghazaleh's path into Medical Affairs and covers topics including the transition from training to industry, the plusses and minuses of clinical practice versus direct industry involvement, internships, challenges of finding a first position, and how to discover your specialty within the function. 

As we all know as per the FDA – October is ‘Cybersecurity Awareness Month’ and today we are going to talk and discuss about this critically important topic. Our objectives for this podcast are as follows: 1. What is medical device cybersecurity – why should you care?2. Why does the FDA and other agencies care about medical device cybersecurity?3. What are the regulatory expectations?